Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
Abstract Background Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs) may have impaired long-term humoral immune responses and increased disease activity after SARS-CoV-2 infection. We aimed to investigate long-term humoral immune responses against SARS-CoV-2 a...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2023-05-01
|
| Серія: | BMC Infectious Diseases |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12879-023-08298-6 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
